Matthew Lang
COO & GC · Structure Therapeutics Inc.
Individual
- 2025
- Apr 23, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Lang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- FMR LLC - $7.06M in GPCR purchases and sales in the last 12 months
- Xichen Lin - $1.47M in GPCR purchases and sales in the last 12 months
- Crespo Blas Coll - $145K in GPCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Lang?
Matthew Lang is a corporate insider, tracked as COO & GC of Structure Therapeutics Inc. (GPCR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matthew Lang last file a Form 4?
The most recent primary Form 4 on record is dated 23 April 2026, one of 2 filings going back to 2025.
